Los Angeles – According to a new study published in Nature, a method for correcting diseases caused by mitochondrial DNA mutations has been developed for somatic cells. However, it is uncertain how this therapy can to be used effectively. Dr. Michael Teitell, a professor of pediatrics and pathology at the University of California, Los Angeles, commented on this method and its place in regenerative medicine.